Figure 1. Binding of Golgi Proteins to p115
Triton X-100-solubilized Golgi membranes were incubated with either control beads or beads containing bound biotin-p115. Total Golgi extract (lanes 1 and 4, 20% of total) and proteins bound to control (lanes 2 and 5) or p115 beads (lanes 3 and 6) were fractionated by SDS-PAGE on a 6% gel and visualized by Coomassie staining (CBB; left panel) or Western blotted with polyclonal antibodies to GM130 (right panel). Molecular mass markers are shown in kDa.
These biochemical experiments also showed that the target for mitotic inhibition was not p115 but the binding sites on Golgi membranes (Levine et al., 1996) . We have (A) Golgi membranes (20 g; lanes 1, 4, and 7), carbonate-washed now identified one of these binding proteins as GM130, (CW) Golgi membranes (20 g; lanes 2, 5, and 8), and immunoprecipitated (IP) GM130 ‫001ف(‬ ng; lanes 3, 6, and 9) were fractionated by originally characterized as a Golgi matrix protein of 130 SDS-PAGE on a 6%-15% gel and either stained with Coomassie kDa . Extraction of Golgi mem- of Golgi stacks (Slusarewicz et al., 1994) . GM130 is a to the position of immunoprecipitated GM130. The IgG heavy (H) component of this matrix, and the sequence predicts and light (L) chains are also marked. Molecular mass markers are shown in kDa.
coiled-coil domains throughout the central region, sug-(B) Golgi membranes (10 g; lanes 1, 4, and 7), purified p115 (280 gesting a jointed rod-like protein. It belongs to an inng; lanes 2, 5, and 8), and a bacterial extract containing truncated creasingly large family of proteins thought to be involved p115 (28 g; lanes 3, 6, and 9) were fractionated by SDS-PAGE on in structural maintenance of the Golgi stack (Nakamura a 6% gel and either stained with Coomassie blue (CBB; left panel), et al., 1995) .
Western blotted with antibodies against p115 (middle panel), or far Western blotted with 35 S-labeled GM130 (right panel). Molecular mass markers are in kDa.
Results p115 Binds to GM130
Purified p115 was biotinylated, bound to streptavidin . As such, it was in a suitable position to tether transport vesicles to Golgi membranes beads, and incubated with a Triton X-100 extract of rat liver Golgi membranes. After washing the beads, bound via p115. Second, we found that this protein bound to p115 in a mitotically regulated manner (see below). As proteins were eluted with buffer containing 0.5 M KCl, fractionated by SDS-PAGE, and visualized by Coomassuch, it could help explain Golgi fragmentation through mitotic inhibition of vesicle docking. sie staining.
As shown in Figure 1 (left panel), control beads bound To demonstrate a direct interaction between p115 and GM130 and not one mediated by p400, far Western a protein of 66 kDa, most likely rat serum albumin, as well as a few minor proteins in the 45-60 kDa range.
blotting was performed. Golgi proteins were fractionated by SDS-PAGE ( Figure 2A ) and either Coomassie p115 beads bound, in addition, two major proteins of 130 kDa and ‫004ف‬ kDa. We focused on p130 protein stained ( Figure 2A , left panel), Western blotted with antibodies to GM130 ( Figure 2A , middle panel), or overlaid for two reasons. First, Western blotting identified it as GM130 (Figure 1, right panel) , a tightly bound peripheral with biotin-p115, which was visualized using HRP-conjugated streptavidin (Figure 2A , right panel). Biotin-p115 protein on the cytoplasmic side of Golgi membranes bound to a protein ( Figure 2A , lane 7) with the same residues upstream of the original predicted start site. Further sequencing using the RACE protocol revealed molecular weight as that recognized by anti-GM130 antibodies ( Figure 2A , lane 4; the lower molecular weight another ATG 12 amino acids further upstream. To determine which of these two start codons was actually used band is a proteolytic degradation product of GM130). Binding was abolished by prior treatment of Golgi memin vivo, GM130 was translated in vitro from each of these two upstream start codons, and the size of the product branes with sodium carbonate , conditions that remove peripheral Golgi proteins includcompared with that of the native protein by SDS-PAGE. Translation from the first ATG yielded a product that was ing GM130 (Figure 2A , lanes 2, 5, and 8). Specific binding to GM130 was confirmed by immunoprecipitating larger, while translation from the second ATG yielded a product with exactly the same molecular weight (data GM130 from a detergent extract of Golgi membranes. The purified protein was visible by Coomassie staining not shown). Since this second ATG was present in the original rat cDNA, the molecular weight and hence ( Figure 2A , lane 3, arrow), together with the heavy and light chains of the antibody (oligomers of which were the designation of the protein as GM130 remains unchanged. The predicted sequence of the new N-termialso present near the top of the gel). This protein was specifically labeled with antibodies to GM130 (Figure nus is shown in Figure 3A , and the complete sequence is available under GenBank accession number U35022. 2A, lane 6) and recognized by biotin-p115 ( Figure 2A , lane 9). The minor band labeled by biotin-p115 is the
The binding site for p115 on GM130 was mapped by deletion analysis. A series of N-terminal and C-terminal abundant antibody heavy chain (cf. Figure 2A , lanes 3 and 9). Other weaker labeling of proteins in Golgi extruncation mutants were constructed, and these are detailed in Figure 3B . They were expressed as 35 S-labeled tracts revealed no consistent pattern between experiments ( Figure 2A , lanes 7 and 8). p400 ( Figure 1 ) was proteins by in vitro transcription/translation and then incubated with p115 beads or beads alone. Bound and not detected either because of poor transfer to the nitrocellulose or poor renaturation.
unbound proteins were then fractionated by SDS-PAGE, and the gel fluorographed. A summary of the results is The converse experiment was also carried out using 35 S-labeled GM130 as the far Western probe. This was provided in Figure 3B , and a selection of the experimental data is presented in Figure 4A . The full-length protein prepared by in vitro transcription/translation of the cDNA for GM130, and it recognized two proteins in fracand the C-terminal deletions all bound to the p115 beads. Binding was typically 70%-80% of the total for tionated rat liver Golgi membranes ( Figure 2B, lane 7) . The upper protein of 130 kDa is GM130 (data not shown), the full-length and ⌬C436, and about 50% for ⌬C237. Binding to the beads was dependent on the presence consistent with our earlier studies showing that GM130 can form oligomeric complexes in detergent with a moof p115, since neither the full-length protein nor any of the constructs bound to beads alone ( Figure 4A , lanes lecular mass in excess of 1 MDa by gel filtration . The lower protein had a molecular 11-14, and data not shown).
In contrast, none of the N-terminal truncations bound weight identical to that of p115, revealed by Western blotting ( Figure 2B , lane 4). Binding to p115 was conto the p115 beads ( Figures 4A and 3B ). Even removal of the first 74 amino acids from GM130 completely abolfirmed in two ways. The first was to purify p115 to near homogeneity ( Figure 2B , lane 2) and show that this proished binding ( Figure 4A , ⌬N75, lanes 3 and 4). To confirm the role played by the N-terminus of GM130 in p115 tein, recognized by anti-p115 antibodies ( Figure 2B , lane 5), was also recognized by 35 S-labeled GM130 ( Figure  binding , a peptide corresponding to this region was synthesized (N73pep; see Figure 3A ). Since the se-2B, lane 8). The second was to express p115 in bacteria so as to eliminate any possibility that GM130 was bindquence predicts removal of the start methionine and acetylation of the exposed serine (Moerschell et al., ing to a protein with the same molecular weight as p115. A truncated form of p115 was used, which lacked most 1990), the peptide was synthesized with acetylated serine at the N-terminus. As shown in Figure 4B , increasing of the globular head. The lysed bacterial extract was fractionated by SDS-PAGE ( Figure 2B , lane 3), the position concentrations of this peptide prevented the binding of full-length GM130 to p115 beads ( Figure 4B , lanes 2-5). of the truncated p115 located by Western blotting (Figure 2B , lane 6), and it was shown to comigrate with the An 80% inhibition was seen at a 17-fold molar excess band revealed by the far Western probe, i.e., 35 S-labeled of peptide over p115 on the beads ( Figure 4B , lane 2). GM130 ( Figure 2B , lane 9). The lower molecular weight Several control peptides derived from p115 and synprotein recognized by anti-p115 antibodies ( Figure 2B , taxin-5 had no effect. An example is shown in Figure  lane 6 ) is a proteolytic fragment that weakly binds to 4B, lane 6. GM130 ( Figure 2B , lane 9). No binding was observed These results establish the binding of p115 to the using lysates from bacteria expressing the vector alone N-terminal region of isolated GM130, but they do not (data not shown).
show that the same binding would occur on intact membranes. To address this, we have used an established in vitro assay to measure binding of p115 to Golgi memThe N-Terminus of GM130 Binds p115 When the predicted sequence of the human GM130 branes (Levine et al., 1996) . p115 was incubated with increasing concentrations of the GM130 N-terminal pep-(Y. Misumi and Y. Ikehara, unpublished data) was compared with that of the rat sequence we originally cloned, tide, and its binding to Golgi membranes quantitated. Preincubation of p115 with a 50-fold excess of N73pep an N-terminal extension was found in the human sequence. This prompted us to reexamine the rat cDNA inhibited binding to Golgi membranes by 60%-70%, while control peptides had no significant effect (Figsequence , and a sequencing error was found that revealed a new in-frame start codon (ATG) 74 amino acid ure 4C). In addition, polyclonal antibodies were raised against N73pep, and their effect on p115 binding was protein could be distinguished from the endogenous GM130 after transient expression in NRK cells. The measured. As shown in Figure 4D , these anti-peptide antibodies inhibited binding by about 60%, while preimcDNAs were microinjected directly into the nucleus, incubated, and then fixed, permeabilized, and double lamune antibodies had no effect.
beled. The results are summarized in Figure 3B , and some of the data is presented in Figure 5 .
The C-Terminus of GM130 Binds Golgi Membranes
The full-length GM130 localized to a compact juxtanuclear reticulum ( Figure 5A ) characteristic of the Golgi The same series of truncation constructs ( Figure 3B ) was used to determine which part of GM130 was responapparatus. This was confirmed by double labeling for the medial and trans marker Mannosidase II (data not sible for the tight binding to Golgi membranes. A Myc tag was placed at the N-terminus so that the expressed shown). The expressed protein could be distinguished (A) N-and C-terminal truncations of GM130 (see Figure 3B ) were constructed and expressed as 35 S-labeled proteins by in vitro transcription/translation. Beads with (lanes 1-10) or without (lanes 11-14) bound biotinp115 were incubated with these labeled proteins and the bound (''B'') and unbound (''U'') fractions were resolved by SDS-PAGE on an 8% gel and detected by fluorography. (B) In vitro-translated 35 S-labeled full-length GM130 was incubated with p115 beads in the absence or presence of increasing concentrations of GM130 N-terminal peptide (N73pep; at 0.5, 1.5, 5, and 15 M, corresponding to a 17, 50, 170, and 500 molar excess over p115, respectively; lanes 2-5) or a control peptide corresponding to amino acids 907-919 of p115 (p115.4, added at a 500 molar excess over p115; lane 6). Bound GM130 was detected by fluorography. (C) p115 was preincubated in the absence (none) or presence of a 15-or 50-fold molar excess of N73pep or control peptide (p115.4). Salt-washed Golgi membranes were added, and bound p115 detected by immunoblotting and quantitated. Results are expressed as the mean Ϯ SEM (n ϭ 4). (D) Salt-washed Golgi membranes were preincubated with or without preimmune antibodies (PI) or anti-N73pep antibodies. p115 was added, the membranes reisolated, and bound p115 detected by immunoblotting and quantitated. Results are expressed as the mean of two experiments, the error bar showing the range. from the endogenous protein by the Myc epitope, but the endogenous GM130 ( Figure 5H ). Second, the endogenous pattern of GM130 was disrupted in NRK cells overconverse was not true because the anti-GM130 antibody used (anti-97 kDa fragment) was against a stretch of expressing the ⌬N690 construct ( Figures 5I and 5L) , consistent with the truncated mutant displacing the enpolypeptide found in both proteins. Nevertheless, the fact that the patterns overlapped almost exactly (cf. dogenous protein. Overexpression did not significantly affect the structure of the Golgi complex, as judged by Figures 5A and 5E ) suggests that the expressed protein localized to the same place as the endogenous GM130, Mannosidase II staining (data not shown). C-terminal deletion mutants confirmed these results. namely the cis-Golgi.
Removal of nearly half the N-terminus had little if any Overexpression of constructs lacking the C-terminal half (⌬C436) or more (⌬C237) of GM130 had no effect on the effect on the targeting of GM130 ( Figure 5B ). This involved removal of the first two coiled-coil domains predistribution of endogenous GM130 ( Figures 5M and 5N ). Together, these data argue that the C-terminal third of dicted from the sequence up to the proline-rich region (construct ⌬N441). Further deletion of coiled-coil do-GM130 is important for Golgi binding and that binding is enhanced by the coiled-coil domain 3 predicted from main 3 (construct ⌬N690) led to cytoplasmic accumulation of the truncated protein and weaker binding to the the sequence. The distribution of p115 was also examined in tranGolgi apparatus ( Figure 5C ). Golgi binding was confirmed using two approaches. First, the ⌬N690 construct siently transfected NRK cells ( Figure 5 , right gallery). p115 in untransfected cells is located on the Golgi appawas tagged with a very sensitive green fluorescent protein (Cormack et al., 1996) . As shown in Figure 5D , the ratus and in the cytoplasm (Sapperstein et al., 1996) . Overexpression of ⌬N690 reduced p115 binding to the reticular staining pattern colocalized exactly with that obtained using an antibody that only recognized the Golgi apparatus ( Figure 5S ), consistent with the fact that it lacks the p115 binding site found on the endogenous GM130, which it appears to displace. Conversely, ⌬C436 and ⌬C237 have the p115 binding site but are unable to bind to Golgi membranes. These cytosolic constructs likely compete with endogenous GM130 for p115, explaining the reduced levels of Golgi-bound p115 ( Figure  5T and 5U). Similar results were also obtained by microinjecting the soluble N-terminal peptide into the cytoplasm ( Figure 5V ), arguing strongly that the N-terminus of GM130 binds to p115 in vivo as well as in vitro.
GM130 Is Modified under Mitotic Conditions
The binding site for p115 on Golgi membranes was earlier shown to be the target for mitotic modification (Levine et al., 1996) . If GM130 is the mitotic target, then it would be expected to undergo modification during 1993) had an apparent molecular mass about 5 kDa larger ( Figure 6B , lane 2) than that in an asynchronous Mitotically Modified GM130 and the N-Terminal population ( Figure 6B , lane 1) and one from which nocoPeptide Do Not Bind to p115 dazole had been removed and the cells allowed to enter Mitotic phosphorylation of GM130 and, in particular, the G1 for 7 hr ( Figure 6B, lane 3) .
N-terminal p115 binding site, suggested the possibility Since the mitotic state is associated with increased that binding was mitotically regulated. Golgi membranes phosphorylation, and the increase in molecular weight were preincubated with cytosol under a variety of inof GM130 was prevented by kinase inhibitors ( Figure  terphase and mitotic conditions, and the membranes 6A), the phosphorylation state of GM130 was examined. solubilized with Triton X-100 and incubated with p115 Golgi membranes were incubated with interphase or beads. All treatments after preincubation with cytosols mitotic cytosol in the presence of [␥-32 P]ATP, and GM130
were carried out in the presence of staurosporine and was immunoprecipitated from the detergent-solubilized microcystin. Staurosporine minimizes phosphorylation membranes. Only the mitotic form of GM130 was phosduring subsequent incubations (such as the p115 on the phorylated ( Figure 6C, lane 4) . beads), and microcystin minimizes dephosphorylation The N-terminal peptide of GM130 was also incubated of modified proteins. The effect is to freeze the phoswith cytosol in the presence of [␥-32 P]ATP ( Figure 6D ).
phorylation state of the sample (see Levine et al., 1996) . The peptide was heavily phosphorylated under mitotic Proteins bound to the p115 beads were then fraction-( Figure 6D , lane 4) but not interphase ( Figure 6D , lane ated by SDS-PAGE and Western blotted for GM130.
2) conditions, and mitotic phosphorylation was inhibited
The results presented in Figure 7A show that GM130 by staurosporine ( Figure 6D, lane 6) . Mitotic phosphoryincubated with interphase cytosol bound to p115 beads lation increased the apparent molecular mass by 1-2 to the same extent as control untreated membranes kDa, less than that observed for GM130 ‫5ف(‬ kDa). This ( Figure 7A, lanes 1 and 2) . In marked contrast, almost either represents phosphorylation elsewhere in the pronone of the mitotically modified GM130 was bound (Figure 7A, lane 3) . Binding was restored if the mitotically tein or anomalous migration on SDS gels. treated Golgi membranes were incubated with interphase cytosol before solubilization and fractionation ( Figure 7A , lane 5). GM130 also bound if the mitotic cytosol was pretreated with either staurosporine ( Figure  7A , lane 4) or olomoucine ( Figure 7A , lane 6) before being used to treat Golgi membranes.
To eliminate any remaining possibility that the effects seen were the consequence of mitotic modification of the p115 on the beads and not the GM130, p115 beads were pretreated with interphase or mitotic cytosol before incubation with Triton X-100 extracts of Golgi membranes. As shown in Figure 7B , the same amount of GM130 bound irrespective of the pretreatment used.
To determine if modification of the GM130 N-terminus is important for regulating the interaction with p115, the GM130 N-terminal peptide was bound to beads, pretreated under various conditions, and binding of p115 to the beads monitored ( Figure 7C ). Untreated peptide beads bound p115 ( Figure 7C , lane 1), as did beads pretreated with interphase cytosol ( Figure 7C , lane 2) or mitotic cytosol inactivated with staurosporine ( Figure  7C , lane 4). The mitotically modified peptide beads bound almost no p115 ( Figure 7C, lane 3) .
The modified peptide was also used to compete with the binding of 35 S-labeled GM130 to p115 beads (see Figure 4B ). As shown in Figure 7D , the binding of 35 Slabeled GM130 ( Figure 7D , lane 1) was reduced by untreated peptide ( Figure 7D , lane 2) and peptide pre- result in the regrowth of single cisternae. In the absence Salt-washed Golgi membranes were then added, incubated for 10 of p115, no regrowth occurs . it mediates the essential role played by p115 during cisternal regrowth, it should be inhibited by the N-terminal GM130 peptide. This is shown in Table 1 . Cisternal 
Salt-washed mitotic Golgi fragments were incubated with the components indicated in the presence or absence of the N-terminal GM130 peptide (N73pep) or control peptide (p115.4). N73pep was added at a 50-fold molar excess over p115 (NSF experiments) or at the same concentration (p97 experiments). a In some experiments, N73pep was pretreated with interphase or mitotic cytosol. b Cisternal regrowth was calculated from the percent membrane in cisternae (% MC) within each experiment by the following equation; results are presented as the mean Ϯ SD.
(% cisternal regrowth) ϭ (% MC after incubation with peptide) Ϫ (% MC before incubation) (% MC after incubation without peptide) Ϫ (% MC before incubation) ϫ 100
c Results are presented as the mean of all experiments Ϯ SD.
regrowth in the absence of peptide was set to 100% A peptide comprising the first 74 amino acids efficiently competed with GM130 for binding to p115 beads. The within each experiment, and the results averaged across peptide also competed with membrane-bound GM130 experiments. The GM130 peptide at a 50-fold molar exfor p115, though the efficiency was less. A 50-fold excess over p115 was inhibitory, reducing the percentage cess of peptide over p115 inhibited binding to native regrowth to 18% Ϯ 10%, whereas a control peptide Golgi membranes by up to 70%, whereas a 17-fold ex-(p115.4) had little if any effect (83% Ϯ 5%). Importantly, cess had a similar effect in detergent extracts. This either preincubation of the GM130 peptide with mitotic cytosol suggests that the detergent conditions lower the binding abolished its inhibitory effect (83% Ϯ 8%), whereas preaffinity of GM130 for p115 or another protein, such as incubation with interphase cytosol did not (10% Ϯ 3%).
the p400 protein (Figure 1 ), is involved in the binding to As a final control, we exploited the fact that cisternae native membranes. This will be resolved once p400 is will also regrow from mitotic fragments in the presence identified. Antibodies raised to the N-terminal peptide of another fusion protein, p97. This fusion protein does confirmed the role played by the N-terminus of GM130. not need p115 for regrowth to occur (Rabouille et al., When used to pretreat Golgi membranes, the binding 1995). As shown in Table 1 , the GM130 peptide had little of p115 was inhibited by about 60%. effect on p97-mediated cisternal regrowth (85% Ϯ 5%).
These biochemical experiments were complemented The results in Table 1 are also presented as the perby transient expression of GM130 constructs in vivo. centage membrane in cisternae averaged across all exThey all disrupted the Golgi localization of p115 but in periments. The pattern of results is exactly the same different ways. The N-terminal deletion constructs were and also shows that the signal to noise of the assay is unable to bind p115, so when they displaced the endogin excess of 2:1. enous GM130, p115 could no longer localize to the Golgi apparatus. Conversely, the C-terminal deletion conDiscussion structs could not bind to Golgi membranes and were dispersed throughout the cytosol. Since they could bind Several lines of evidence identify GM130 as a binding to p115, they presumably competed effectively with ensite for the vesicle docking protein p115. GM130 was dogenous GM130 for the available p115. Similar results one of only two proteins in Triton-solubilized extracts of were obtained by microinjection of the N-terminal pepGolgi membranes that bound specifically to immobilized tide into the cytosol, strongly suggesting that it can also p115. In vitro-transcribed and -translated GM130 recogbind to p115 in vivo. nized p115 in overlay blots of the pure protein and in
The binding domain on GM130 for Golgi membranes whole Golgi extracts. In the latter extracts, it also recogwas in the C-terminal half of the protein. Transient transnized itself, consistent with earlier work suggesting that fection showed that constructs lacking this half (or more) GM130 can form oligomeric complexes (Nakamura et of the protein were unable to bind to Golgi membranes al., 1995) . The converse experiment also worked with or compete with endogenous GM130 even when overexbiotinylated p115, specifically recognizing GM130 in pressed. A construct comprising the C-terminal third of whole Golgi extracts and immunopurified preparations.
GM130 was able to do both, though binding to Golgi The binding site for p115 appeared to be at the membranes was not as efficient as a construct compris-N-terminus of GM130. Deletion of only 74 N-terminal ing the C-terminal half. This was able to bind as well as amino acids abolished binding to p115 beads. C-termithe full-length protein. The results suggest that the acnal deletions showed that just over half of the protein tual binding domain is toward the C-terminus but binding is stabilized by other sequences in the C-terminal could be removed with little effect on binding efficiency.
half. Experiments are now in progress using C-terminal that the increase was only 1-2 kDa. It remains to be sequences to identify the precise Golgi binding site for seen whether this represents additional phosphorylation GM130.
of other parts of the GM130 molecule and whether this A direct homolog of GM130 has not been found in the has functional significance. Experiments are in progress yeast genome database. Interestingly, the protein that using purified protein kinases to identify those responsiconsistently gives the highest homology is Uso1p, the ble. It is interesting to note in this regard that the homology residing in the tail region. Since the tail in N-terminal peptide has two putative cyclin-dependent Uso1p is three times longer than that in p115 (Sapkinase phosphorylation sites (boxed regions in Figure  perstein Yamakawa et al., 1996) , this raises 3A) (Songyang et al., 1994) , which could serve to regulate the interesting possibility that Uso1p is a fusion of p115 p115 binding. The binding of GM130 to Golgi memand GM130. In other words, GM130 would represent branes is unlikely to be regulated, since mitotic phosthe extra long tail found in Uso1p but not p115. The phorylation both in vivo and in combined molecular mass of p115 and GM130 (218 kDa) vitro ( Figure 6A ) did not release GM130 from the memis certainly close to that of Uso1p (206 kDa). One would brane. also expect that Uso1p could not be susceptible to the The functional significance of this mitotic regulation type of mitotic regulation seen with p115 and GM130.
was tested using a Golgi reassembly assay. Mitotic This is consistent with the fact that membrane traffic Golgi fragments will reform cisternae in the presence of through the yeast Golgi is not disrupted during mitosis, either NSF or p97. The NSF-dependent reassembly is as it is in mammalian cells when the Golgi apparatus absolutely dependent on the presence of p115, and refragments (Warren, 1993) . This speculation would mean assembly was shown to be inhibited by the N-terminal that the Golgi binding site for Uso1p should be the same GM130 peptide. The peptide limited cisternal regrowth as that for GM130. It will therefore be important to search to 18% at a 50-fold molar excess over p115. The specifor Uso1p-binding proteins in yeast membrane extracts.
ficity was confirmed using an irrelevant p115 peptide It will also be necessary to analyze in more detail the and by the fact that the GM130 peptide had no effect GM130 binding sites on p115. It is interesting that our on the p97 reassembly pathway. Most importantly, the preliminary experiments ( Figure 2B ) show efficient bindinhibition was only seen using the untreated peptide or ing to a truncated p115 lacking about two-thirds of the one treated with interphase cytosol. Pretreatment of globular head but containing the entire tail region.
the peptide with mitotic cytosol abolished its inhibitory The binding of p115 to GM130 was shown to be mitotieffect. These data provide strong evidence in vitro that cally regulated. Preincubation of Golgi membranes with the regrowth of Golgi cisternae is dependent on the mitotic cytosol prevented the binding of detergent-soluinteraction of p115 with GM130 through the N-terminal bilized GM130 to p115 beads. Pretreatment of p115 region. Furthermore, the absence of this interaction unbeads had no effect, consistent with earlier work showder mitotic conditions could help explain the observed ing that the target of mitotic regulation was the p115 fragmentation of the Golgi apparatus through inhibiting binding site, not p115 itself (Levine et al., 1996) . The the docking of transport vesicles with their target memeffect was reversible upon subsequent incubation with brane. Specifically, it could explain the COPI-dependent interphase cytosol and prevented by prior treatment of pathway of fragmentation . the mitotic cytosol with either the general kinase inhibi-GM130 is enriched on cis-Golgi membranes (Nakator, staurosporine, or the specific CDK inhibitors, olomura et al., 1995) and so could service incoming COPI moucine and roscovitine. Mitotic regulation could be and COPII vesicles on the anterograde pathway, as well mimicked by the N-terminal GM130 peptide. When preas providing a staging post for retrograde COPI vesicles treated with mitotic cytosol, the peptide was unable on their way from the Golgi stack back to the ER (Bedto prevent binding of p115 to native GM130 on Golgi narek et al., 1996) . Low levels of GM130 might even be membranes. Inactivation of the mitotic cytosol with present on trans-Golgi membranes to receive anterostaurosporine prevented this effect. Furthermore, when grade COPI vesicles moving through the Golgi stack the peptide was bound to beads and incubated with (Malhotra et al., 1989; Rothman and Wieland, 1996) . mitotic cytosol, subsequent binding of p115 was almost There is, however, no evidence that GM130 is present completely abolished, an effect prevented by prior treaton those regions of the ER set up to receive retrograde ment of the cytosol with staurosporine. The inhibition COPI vesicles. The possibility of another binding site is of p115 binding is likely a direct effect of mitotic modifipresently being tested by repeating the p115-binding cation of the bound peptide, rather than an indirect one experiments using detergent-solubilized ER memmediated by a component of mitotic cytosol that only branes. binds to the mitotically modified peptide. The bound peptide was the major protein in the mitotic incubation (constituting about 2% of the total protein), and the
Experimental Procedures
beads were thoroughly washed with 1 M salt before incubation with p115.
Molecular Cloning
The Marathon cDNA Amplification Kit (Clontech) was used to generMitotic regulation of GM130 and the N-terminal pepate new GM130 clones by 5Ј RACE , the tide resulted in characteristic changes in the level and longest of which had a 69 bp extension. A partial cDNA fragment pattern of phosphorylation. GM130 was only phosphoryof p115 was isolated during screening for GM130 clones (Nakamura lated significantly by mitotic, not interphase cytosol, et al., 1995) and corresponded to the C-terminal 354 amino acids resulting in a reversible increase in apparent molecular (Sapperstein et al., 1995) . It was expressed as a His-tagged protein mass of about 5 kDa that was prevented by kinase inhibiusing pQE10 (Qiagen).
Truncated cDNA constructs of GM130 were generated by PCR tors. Similar effects were seen using the peptide except using appropriate oligonucleotide primers and cloned into pBSI Treatments with Mitotic and Interphase Cytosols Cytosols (Stuart et al., 1993) were prepared without phosphatase IKS ϩ , verified by sequencing, and translated in vitro . For expression in vivo, the cDNAs were subcloned into inhibitors and desalted into MEB buffer immediately prior to use . Typically, 40 g Golgi membranes was mixed pCMUIV (Nilsson et al., 1989 ) and tagged at the N-terminus with MPEQKLISEEDLPSMPLR (Myc epitope underlined). For construct with 2.5 mg cytosol supplemented with an ATP-regenerating system in a final volume of 300 l and warmed to 37ЊC for 10 min in the ⌬N690, the complete coding sequence of GFP (Cormack et al., 1996) was cloned after the Myc epitope.
presence or absence of inhibitors (see legends to Figures 6 and 7) . Mitotically treated membranes were reverted by subsequent incubation for 10 min with interphase cytosol. Twenty-five micromolars Microinjection and Immunofluorescence Microscopy staurosporine and 10 M microcystin were added at the end to Plasmid DNA was microinjected into the nucleus of NRK cells for prevent further changes in the phosphorylation state, and memlow (20 g/ml for 8 hr) or high (80 g/ml for 4 hr) expression levels.
branes were reisolated by centrifugation at 100,000 ϫ g for 10 min. N73pep (5 mg/ml with Cascade blue-BSA as a marker) was microinN73pep (5 g) or 2.5 l N73pep beads were phosphorylated by jected into the cytoplasm, and the cells incubated for 1 hr. Cells incubation with 250 g cytosolic protein in 25 l for 30 min at 37ЊC. were processed for epifluorescence or confocal microscopy (NakaIn some incubations, the ATP-regenerating system was replaced mura et al., 1995) .
by [␥-32 P]ATP at 1 Ci/l. Coupling to Streptavidin Beads Rat liver p115 (Levine et al., 1996) was biotinylated using NHSReassembly Assay LC-biotin (Pierce) (10 g p115/g biotin) according to the manufacSalt-washed mitotic Golgi fragments were incubated with NSF, ␣-turers instructions. It was coupled to ''Ultralink'' streptavidin beads and ␥-SNAPs, and p115, or with p97 . In (Pierce) (0.3 g biotin-p115/l) in HKT buffer (10 mM HEPES [pH competition experiments, p115 was preincubated for 30 min on ice 7.4], 100 mM KCl, 0.25% Triton X-100, 1 mM EDTA, 0.5 mM DTT) with a 50-fold molar excess of peptide. Where stated, N73pep was for 2 hr at 4ЊC. N73pep was synthesized with an N-terminal biotin preincubated with interphase or mitotic cytosol at 37ЊC for 30 min. group and incubated at 2 g peptide/l streptavidin beads. After
Membranes were processed for EM and quantitated (Rabouille et coupling, beads were blocked with 5 mg/ml soybean trypsin inal., 1995) . hibitor.
